Fundz

Axmed raises $2M in seed funding led by Founderful to enhance healthcare access in emerging markets

PRIVATEMay 08, 2024

Amount Raised

$2 Million

Round Type

Seed

Health CareMarketplace

Investors

Founderful

Description

Axmed, a two-sided B2B marketplace platform, has raised $2 million in seed funding led by Founderful. The investment aims to accelerate the affordability, availability, and distribution of essential and innovative medicines in underserved regions, particularly in African and Caribbean markets.

Quick answer

Axmed raised $2 Million in a Seed round, dated May 8, 2024. Investors: Founderful.

How much did Axmed raise?
Axmed raised $2 Million in a Seed round on May 8, 2024.
Who invested in Axmed?
Founderful is named as investors in this round.
What does Axmed do?
Axmed is a medicines marketplace that unlocks access to life-saving therapeutics by aggregating demand across healthcare providers (governments, INGOs, private providers).
Who are the decision-makers at Axmed?
Fundz holds 1 contact at Axmed. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Marketplace and Health Care around the same time

Companies in the same sectors as Axmed that raised within 45 days of this round, from Fundz verified event records.

  • Aligned Marketplace raised $8M (Seed) on April 6, 2024.
  • Recare raised $3.5M (Seed) on April 2, 2024.
  • Sava raised $8M (Seed) on June 21, 2024.
  • HOMA2u raised $1.5M (Pre-Series A) on June 21, 2024.
  • HealthPresso raised $1M (Pre-Series A) on June 21, 2024.
  • Lillian Care raised $1.6M (Funding Round) on June 21, 2024.

Who to call at Axmed, and when

A new round usually means Axmed is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Axmed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Axmed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Axmed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Axmed

About

Axmed is a medicines marketplace that unlocks access to life-saving therapeutics by aggregating demand across healthcare providers (governments, INGOs, private providers). Our business model strengthens purchasing power with manufacturers to ensure the supply of cost-effective, high-quality medicines to patients at transparent prices. We partner exclusively with authorized, high quality pharmaceutical companies and certified caregivers to accelerate sustainable access to medicines .

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Axmed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Axmed's next move

See what Strategic adds

Axmed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.